The Israeli government is ready to host a group of Filipino experts to share its strategies and technologies in effectively stopping the spread of Covid-19.
The planned visit was revealed by Israeli Ambassador to the Philippines Ilan Fluss on Thursday during the “Dealing with Delta and other Pandemic Challenges Lessons” forum organized by the Israel Chamber of Commerce of the Philippines.
“Israel has innovations and quite a lot of new developments and we’d like to share (these) with the Philippines and this delegation, who we hope will visit this November. (They) would be able to see with their own eyes what are the opportunities and we’d be happy to share them,” he said.
Last July, a team of Israeli medical experts also visited Manila to share their success in the national vaccination campaign, which was followed by another group in August.
The second delegation gave their recommendations on ways to further improve systems and procedures in handling Covid-19 patients, including infection control protocols and hospital management.
Israel has been hailed for its rapid vaccination drive, successfully inoculating 70.7 percent of its population as of October 19.
It was also among the first countries to rollout booster shots after experiencing a dramatic increase in its Covid-19 cases last June and July despite the number of its fully vaccinated citizens.
Although the Delta outbreak is still not over, Prime Minister Naftali Bennett earlier said Israel is now starting to overcome this wave, giving credit to the country’s pandemic management strategies including the aggressive booster campaign and introduction of “green pass” for fully inoculated individuals to access events and facilities like cinemas, hotels, etc.
In the Thursday forum, infectious diseases and Covid-19 specialist Guy Chosen noted that booster shots have now become Israel’s “main mitigation tool” against the Delta variant. ”
[W]e could continue and operate our commercial life, our cultural life, sports events, education system during the fourth Delta wave thanks to the rollout and effectiveness of the third dose, the booster campaign,” he said.
Citing a research published on medRxiv this October, Chosen said the rate of coronavirus infection and severe illness across all age groups was “substantially lower among those who received a booster dose of the Pfizer vaccine.” The said study is based on the Israeli government’s database from the period July 30 to Oct. 6 on over 4 million people aged 16 and above, who have been fully inoculated at least five months earlier.